Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold
Receptor-interacting protein kinase 2 (RIPK2) is a key mediator of nucleotide-binding oligomerization domain (NOD) cell signaling that has been implicated in various chronic inflammatory conditions. A new class of RIPK2 kinase/NOD signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold...
Main Authors: | Suebsuwong, C, Dai, B, Pinkas, DM, Duddupudi, AL, Li, L, Bufton, JC, Schlicher, L, Gyrd-Hansen, M, Hu, M, Bullock, AN, Degterev, A, Cuny, GD |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling
by: Nikhar, S, et al.
Published: (2021) -
Small-molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
by: Gyrd-Hansen, M, et al.
Published: (2018) -
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
by: Suebsuwong, C, et al.
Published: (2018) -
Inflammatory signaling by NOD-RIPK2 is inhibited by clinically relevant type II kinase inhibitors
by: Canning, P, et al.
Published: (2015) -
RIPK2 NODs to XIAP and IBD
by: Topal, Y, et al.
Published: (2020)